Rare-Disease Diagnostics
ARCHIMEDlife
A leading provider of specialty diagnostic services, software and data to the healthcare sector.
ARCHIMEDlife is a leading provider of specialty diagnostic services, software and data to the healthcare sector, headquartered in Vienna. With strong market positions across Austria, Germany and international referral markets, ARCHIMEDlife plays a central role in rare disease testing and diagnostic pathways, whether initiated by patients, physicians or corporates, directly or through healthcare institutions and pharmaceutical partners. It is a preferred partner for these services and an essential part of the diagnostic value chain, with the core global business also providing embedded workflow software and data analytics.
The group delivers integrated solutions across three complementary service lines: (i) Diagnostics, Testing and Advisory; (ii) Software; and (iii) Intelligence. When a rare or complex condition is investigated in Austria, Germany or its international markets, ARCHIMEDlife is often the provider behind the diagnostic advisory, the software used and the data that supports the clinical decision.
ARCHIMEDlife supports a broad and diverse customer base with diagnostics-related services, including newborn and high-risk screening, biomarker and monitoring programmes, clinical trial and biopharma support, and workflow software. With Longevity Industries' support, the company has accelerated investment in technology, data and software, helping its clients become more scalable and efficient.